Position in ANNX
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$159,214
+$98,022 QoQ
Shares Held
28,739
+142.8% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ANNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MIRABELLA FINANCIAL SERVICES LLP holds $8,690,870 across 20 Biotechnology names. ANNX ranks #7 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HRMY |
Harmony Biosciences Holdings, Inc.
|
115,934 | $3,247,311 | |
| 2 | OCUL |
Ocular Therapeutix, Inc
|
294,628 | $2,495,499 | |
| 3 | ABVX |
Abivax S.A.
|
4,256 | $473,905 | |
| 4 | CORT |
Corcept Therapeutics Inc
|
10,188 | $410,678 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
1,557 | $294,350 | |
| 6 | NAGE |
Niagen Bioscience, Inc.
|
43,074 | $189,956 | |
| 7 | ANNX |
Annexon, Inc.
This page
|
28,739 | $159,214 | |
| 8 | ADMA |
Adma Biologics, Inc.
|
17,644 | $158,972 |
All Filings in ANNX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $159,214 | 28,739 | Shares | Sole | 2026-05-12 | |
| 2022-12-31 | $61,192 | 11,836 | Shares | Sole | 2023-02-13 | |
| 2021-09-30 | $262,773 | 14,120 | Shares | Sole | 2021-11-15 | |
| 2020-09-30 | $243,593 | 8,058 | Shares | Sole | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||